Charles E Bugg - Net Worth and Insider Trading
Charles E Bugg Net Worth
The estimated net worth of Charles E Bugg is at least $1 Million dollars as of 2024-11-13. Charles E Bugg is the Chairman of BioCryst Pharmaceuticals Inc and owns about 135,577 shares of BioCryst Pharmaceuticals Inc (BCRX) stock worth over $1 Million. Details can be seen in Charles E Bugg's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Charles E Bugg has not made any transactions after 2006-03-03 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Charles E Bugg
Charles E Bugg Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Charles E Bugg owns 1 companies in total, including BioCryst Pharmaceuticals Inc (BCRX) .
Click here to see the complete history of Charles E Bugg’s form 4 insider trades.
Insider Ownership Summary of Charles E Bugg
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| BCRX | BioCryst Pharmaceuticals Inc | 2006-03-03 | director & CEO |
Charles E Bugg Latest Holdings Summary
Charles E Bugg currently owns a total of 1 stock. Charles E Bugg owns 135,577 shares of BioCryst Pharmaceuticals Inc (BCRX) as of March 3, 2006, with a value of $1 Million.
Latest Holdings of Charles E Bugg
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| BCRX | BioCryst Pharmaceuticals Inc | 2006-03-03 | 135,577 | 7.82 | 1,060,212 |
Holding Weightings of Charles E Bugg
Charles E Bugg Form 4 Trading Tracker
According to the SEC Form 4 filings, Charles E Bugg has made a total of 0 transactions in BioCryst Pharmaceuticals Inc (BCRX) over the past 5 years. The most-recent trade in BioCryst Pharmaceuticals Inc is the sale of 50,000 shares on March 3, 2006, which brought Charles E Bugg around $1 Million.
Insider Trading History of Charles E Bugg
- 1
Charles E Bugg Trading Performance
Charles E Bugg Ownership Network
Ownership Network List of Charles E Bugg
Ownership Network Relation of Charles E Bugg
Charles E Bugg Owned Company Details
What does BioCryst Pharmaceuticals Inc do?
Who are the key executives at BioCryst Pharmaceuticals Inc?
Charles E Bugg is the director & CEO of BioCryst Pharmaceuticals Inc. Other key executives at BioCryst Pharmaceuticals Inc include Chief Financial Officer Anthony Doyle , Vice President and CCO Charles K Gayer , and VP & General Counsel & Corp Sec Alane P Barnes .
BioCryst Pharmaceuticals Inc (BCRX) Insider Trades Summary
Over the past 18 months, Charles E Bugg made no insider transaction in BioCryst Pharmaceuticals Inc (BCRX). Other recent insider transactions involving BioCryst Pharmaceuticals Inc (BCRX) include a net sale of 8,689 shares made by Machelle Sanders , a net sale of 7,866 shares made by Nancy J Hutson , and a net purchase of 36,300 shares made by Anthony Doyle .
In summary, during the past 3 months, insiders sold 0 shares of BioCryst Pharmaceuticals Inc (BCRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 36,853 shares of BioCryst Pharmaceuticals Inc (BCRX) were sold and 183,601 shares were bought by its insiders, resulting in a net purchase of 146,748 shares.
BioCryst Pharmaceuticals Inc (BCRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
BioCryst Pharmaceuticals Inc Insider Transactions
Charles E Bugg Mailing Address
Above is the net worth, insider trading, and ownership report for Charles E Bugg. You might contact Charles E Bugg via mailing address: C/o Biocryst Pharmaceuticals, Inc, 2190 Pkwy Lake Drive, Birmingham Al 35244.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
